Flow Traders U.S.’s Tema Oncology ETF CANC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$785K Buy
+21,384
New +$778K 0.02% 517
2025
Q4
Sell
-21,939
Closed -$630K 935
2025
Q3
$630K Buy
+21,939
New +$583K 0.03% 550

Other funds holding CANC

Flow Traders U.S.'s CANC Position: Q1 2026 in Review

Flow Traders U.S. opened a new position in Tema Oncology ETF (CANC) in Q1 2026: 21,384 shares worth $785K. The stake represents 0.02% of the portfolio and ranks #517 among its holdings. This is a return to the name: Flow Traders U.S. previously reported a position in CANC as recently as Q3 2025.

Flow Traders U.S. first reported a position in CANC in Q3 2025 and has held it in 2 quarters since. 12 funds tracked by Wall St. Rank hold CANC as of Q1 2026.

  • Flow Traders U.S. held 21,384 shares of Tema Oncology ETF worth $785K as of Q1 2026.
  • Tema Oncology ETF was a new Flow Traders U.S. position in Q1 2026.
  • Tema Oncology ETF made up 0.02% of Flow Traders U.S.'s portfolio in Q1 2026, its #517 holding.
  • Flow Traders U.S. first reported a position in Tema Oncology ETF in Q3 2025 and has held it in 2 quarters since.
  • 12 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q1 2026.

Based on Flow Traders U.S.'s 13F filing for Q1 2026, filed 15 May 2026.